New drug targets stubborn tremors in Parkinson's
NCT ID NCT05642442
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a drug called suvecaltamide for people with Parkinson's disease who still have moderate to severe tremor despite taking other medications. Over 17 weeks, 169 participants received either the drug or a placebo, with doses adjusted for best effect. The goal was to see if the drug could reduce tremor and improve daily activities like eating and dressing.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- suvecaltamide
- What this could lead to
- If it works, this could lead to a new option for controlling stubborn tremor in Parkinson's disease that standard medications don't fully manage.
- What could go wrong
- This is an early Phase 2 trial with only 169 people, so results may not apply broadly. The drug may not prove more effective than placebo, and side effects are still being studied.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Albany Medical College
Albany, New York, 12208, United States
-
Central Texas Neurology Consultants
Round Rock, Texas, 78681, United States
-
Centrum Medyczne Plejady
Krakow, 30-363, Poland
-
Clinical Neuroscience Solutions, Inc.
Jacksonville, Florida, 32256, United States
-
Columbia University Irving Medical Center
New York, New York, 10032, United States
-
Curiositas-ad-sanum Beratungs-und Studien GmbH
Haag in Oberbayern, 83527, Germany
-
Dent Neurologic Institute
Amherst, New York, 14226, United States
-
Deutsche Klinik fur Diagnostik Helios Klinik Wiesbaden
Hessen, 65191, Germany
-
ETG Neuroscience Sp. z o.o.
Warsaw, 02-777, Poland
-
EverGreenHealth Neuroscience Institute
Kirkland, Washington, 98034, United States
-
Gabinety Lekarskie Rivermed Sp. z o.o.
Poznan, 61-441, Poland
-
Hawaii Pacific Health
Honolulu, Hawaii, 96817, United States
-
Hospital Ramón y Cajal
Madrid, 28034, Spain
-
Hospital Universitario Cruces
Barakaldo, 48903, Spain
-
Hospital Universitario Virgen Macarena
Seville, 41009, Spain
-
Hospital Universitario de La Princesa
Madrid, 28006, Spain
-
Hospital de la Santa Creu i Sant Pau
Barcelona, 08041, Spain
-
Keck School of Medicine of University of Southern California (USC)
Los Angeles, California, 90033, United States
-
Maxxmed Centrum Zdrowia i Urody w Lublinie
Lublin, 20-080, Poland
-
Movement Disorders Center of Arizona
Scottsdale, Arizona, 85258, United States
-
NeuroTrials Research Inc.
Atlanta, Georgia, 30328, United States
-
Neurologia Slaska Centrum Medyczne
Katowice, 40-689, Poland
-
Neurology of Central Florida Research Center LLC
Altamonte Springs, Florida, 32714, United States
-
Niepubliczny Zaklad Opieki Zdrowotnej Neuromed M.i M. Nastaj Spólka Partnerska
Lublin, 20-064, Poland
-
Northwestern Medical Group, Department of Neurology
Chicago, Illinois, 60611, United States
-
Parkinson's Disease and Movement Disorder Center of Boca Raton
Boca Raton, Florida, 33486, United States
-
Pharmakologisches Studienzentrum Chemnitz GmbH
Chemnitz, 091111, Germany
-
South Shore Neurologic Associates PC
Patchogue, New York, 11772, United States
-
The Nene and Jamie Koch Comprehensive Movement Disorders Center
Albuquerque, New Mexico, 87106, United States
-
USF Parkinson's Disease and Movement Disorders Center
Tampa, Florida, 33613, United States
-
University of Cincinnati Gardner Neuroscience Institute (UCGNI)
Cincinnati, Ohio, 45219, United States
-
University of Colorado Hospital Anschutz Outpatient Pavilion
Aurora, Colorado, 80045, United States
-
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
-
University of Kentucky, College of Medicine, Department of Neurology
Lexington, Kentucky, 40536, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
-
Velocity Clinical Research Germany GmbH, Location Wiesbaden
Wiesbaden, 65189, Germany
-
Zentrum f. klinische Forschung Dr. I. Schöll
Bad Homburg, 61350, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood-flow cuffs may mimic exercise to ease Parkinson's symptoms
- Shake or sync: two therapies put to the test for Parkinson's mobility
- Wearable sensors aim to catch neurodegenerative decline in real time
- Can deep brain stimulation rewire faulty movement circuits? a surgery-time study aims to find out.
- The eyes as a window to the brain: can a simple scan monitor MS, Alzheimer's, and Parkinson's?
- Could a simple bowel rinse ease Parkinson's constipation and movement problems?